Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer

NCT00923273 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

42

Enrollment

NIH

Sponsor class

Stopped Premature closure - investigator left the National Institutes of Health.

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: FDG-PET
DRUG: Pemetrexed
DRUG: Sirolimus
DIETARY_SUPPLEMENT: Vitamin B12
DIETARY_SUPPLEMENT: Folic acid tablets
DRUG: Dexamethasone tablets

Sponsor

National Cancer Institute (NCI)